CSL (ASX:CSL) share price history: The major highlights (and low points)

We take a deep dive into CSL's share price history…

| More on:
A woman looks quizzical as she looks at a graph of the share market.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

Of all the ASX 200 blue chip shares, none arguably has a more interesting share price history than that of CSL Limited (ASX: CSL), the giant healthcare company that dominates the S&P/ASX 200 Index (ASX: XJO). CSL is presently the second-largest company on the ASX boards, just behind Commonwealth Bank of Australia (ASX: CBA).

But it's had quite the history over the past 10 years. CSL used to be regarded as something of a perfect ASX blue chip growth share. It could seemingly do no wrong, rising in value year after year, and often by double-digits.

But the company's fortunes have looked a whole lot different over the past 2 years or so. But enough with the words, let's put this in some visual context:

CSL share price history visualised

CSL share price
CSL 10-year share price and data | Source: fool.com.au

As you can clearly see above, we can see three different growth phases playing out: virtually uninterrupted share price growth from 2012 to late 2018. Share price growth resuming from early 2019 to early 2020. And a now-long period of stagnation stretching from the onset of the coronavirus pandemic until today.

Yes, CSL shares did have some major pullbacks, most notably in late 2016, mid-2017 and late 2018. Some of these pullbacks were rather dramatic too. For example, between August and December 2018, CSL shares lost more than 20% of their value. But the shares went on to recover every time.

Well, at least until the pandemic. As is evident above, CSL has unequivocally been stuck in something of a funk for the past 18 months or so. The company remains roughly 12% below its all-time high of $$336 a share that we saw back in February 2020. That's on the CSL share price of $297.02 at the time of writing.

Even so, the raw data shows CSL has given its shareholders a capital return of roughly 894% over the past decade (not including dividend returns). That represents a compound annual growth rate of 25.8% per annum over the decade. Nothing to complain about there!

At the current CSL share price of $297.02, this company has a market capitalisation of $134.7 billion, a price-to-earnings (P/E) ratio of 42.6 and a dividend yield of 0.99%.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Healthcare Shares

Up 29% this year, does Macquarie expect Medibank Private shares to continue rising?

Medibank's explosive share price growth has caught the eye of this broker.

Read more »

Man in business suit carries box of personal effects
Healthcare Shares

Monash IVF shares jump 9% as CEO quits after second embryo incident

Two incidents at its clinics have cost this CEO his job.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Guess which ASX 200 stock turned $5,000 into $34,264 in just three years!

Investors have been piling into this ASX 200 stock for years, sending the share price soaring.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Healthcare Shares

Cochlear shares sink 9% on guidance downgrade

Investors haven't responded positively to this update. Let's dig deeper into it.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Telix shares push higher on investor day update

This radiopharmaceuticals company has grand plans for the future.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

3 leading ASX healthcare shares with global reach

These 3 healthcare companies are having an outsized impact far beyond local markets.

Read more »

Man looks shocked as he works on laptop on top a skyscraper with stockmarket figures in graphic behind him.
Healthcare Shares

Macquarie tips more than 100% upside for this ASX All Ords healthcare stock

This company could be set to soar.

Read more »

A little boy, soon to be a brother, kisses and holds his mum's pregnant tummy.
Healthcare Shares

Monash IVF shares fall 25% following second embryo incident

Its been a forgettable start to 2025 for Monash IVF shareholders.

Read more »